The financing round was led by Next47 with participation from Partech, pushing the company valuation to $100m.
"This new investment fuels the scaling of Blink’s all-in-one employee retention platform in the midst of a global recruitment crisis. As labour shortages hit industries with historically high staff turnover, such as healthcare, it’s clear that wages aren’t the only factor driving employees away. Using Blink has become a competitive advantage in the battle for talent, with organizations using the app to attract and retain their frontline workforce."
The funding round includes backing from strategic and regional investors to support the rollout of Female Hormone Mapping.
"Today, more and more people are realising that understanding and measuring your body’s biochemistry is key for a long and healthy life. For women in particular, gaining unique insight into how their hormone levels fluctuate throughout their unique cycle can give women the support they have been lacking and help to close the gender health gap"
Blackfinch Ventures led the Series A round to support product development and company growth.
"Every company has its own unique set of safety challenges. Interventions such as training and processes only go so far to improve safety. We’re helping companies uncover and understand the underlying influences of unsafe actions and provide the resources to help them change those behaviours."
The investment will support expansion in the United States and the ongoing development of the company data platform.
"The whole team is excited to take the next step to further support organisations in driving value from their data, so that they can achieve their business goals. The investment from Octopus Ventures is a fantastic affirmation of the scale of impact we’ve been able to deliver to our customers. We look forward to working with Octopus to further develop our product and expand into new markets."
